Markets & Stocks

Cannabis Stocks Today — Monday 16 November 2026: Aurora sits at $4.94

Cannabis shares start the week on the back foot, with losses reaching Canadian producers and US operators alike.

Business of Cannabis Business Brief

Cannabis shares start the week on the back foot, with losses reaching Canadian producers and US operators alike. With the US session still in pre-market, 24 of the 35 cannabis-linked tickers tracked by Business of Cannabis sit below their previous close, and the AdvisorShares Pure US Cannabis ETF (MSOS) trades at $3.72, down 3.63%. Curaleaf, which led Friday’s report at $8.06, now sits at $7.85. Quotes reflect the latest completed session, and OTC names can lag by a trading day.

Eleven of the 35 trade above their previous close, and most of those are adjacent names rather than plant-touching operators. Altria trades at $78.64 (+0.92%) and Innovative Industrial Properties at $53.02 (+0.68%). Among operators, Cresco Labs (CRLBF) leads at $0.50, up 4.82%, with Ascend Wellness at $0.36 (+2.77%) and IM Cannabis at $0.5682 (+2.75%). The heaviest declines sit with Glass House (GLASF) at $2.26 (-12.40%) and Vext Science at $0.13 (-10.34%). The Amplify Alternative Harvest ETF (MJ) sits at $21.35, down 2.51%, and CNBS trades at $21.70, down 3.16%.

Ticker Company Current Price Change ($) Change (%)
GLASF Glass House Brands $2.26 −$0.32 −12.40%
VEXTF Vext Science $0.1300 −$0.01 −10.34%
CRLBF Cresco Labs $0.5000 +$0.02 +4.82%
VFF Village Farms $2.42 −$0.12 −4.72%
IPW iPower $1.24 −$0.05 −3.88%
MSOS AdvisorShares Pure US Cannabis ETF $3.72 −$0.14 −3.63%
CNBS Amplify Seymour Cannabis ETF $21.70 −$0.71 −3.16%
AAWH Ascend Wellness $0.3600 +$0.01 +2.77%
IMCC IM Cannabis $0.5682 +$0.02 +2.75%
CURLF Curaleaf Holdings $7.85 −$0.21 −2.61%
MJ Amplify Alternative Harvest ETF $21.35 −$0.55 −2.51%
IXHL Incannex Healthcare $1.97 −$0.05 −2.48%
TLRY Tilray Brands $2.43 −$0.06 −2.41%
CBWTF Auxly Cannabis $2.49 −$0.06 −2.35%
YOLO AdvisorShares Pure Cannabis ETF $2.50 −$0.06 −2.34%
CGC Canopy Growth $0.5612 −$0.01 −2.20%
REFI Chicago Atlantic Real Estate Finance $8.61 −$0.19 −2.16%
GRWG GrowGeneration $1.25 +$0.02 +1.63%
GTBIF Green Thumb Industries $6.12 −$0.10 −1.61%
SNDL SNDL $1.37 −$0.02 −1.44%
HITI High Tide $2.47 −$0.03 −1.20%
ACB Aurora Cannabis $4.94 −$0.05 −1.00%
MO Altria Group $78.64 +$0.72 +0.92%
CRON Cronos Group $3.38 −$0.03 −0.88%
MAPS WM Technology $0.1906 +$0.00 +0.85%
JUSHF Jushi Holdings $0.3900 −$0.00 −0.84%
STZ Constellation Brands $145.61 +$1.01 +0.70%
IIPR Innovative Industrial Properties $53.02 +$0.36 +0.68%
OGI Organigram $0.8286 −$0.01 −0.65%
AFCG AFC Gamma $3.32 −$0.02 −0.60%
CRBP Corbus Pharmaceuticals $3.39 −$0.02 −0.59%
JAZZ Jazz Pharmaceuticals $241.55 +$1.18 +0.49%
TPB Turning Point Brands $55.55 −$0.20 −0.36%
ABBV AbbVie $295.03 +$0.58 +0.20%
SMG Scotts Miracle-Gro $63.84 +$0.10 +0.16%

Aurora Cannabis (ACB) sits at $4.94, down 1.00%, below the headline value of both offers for the company. Organigram agreed on 3 November to buy Aurora for C$7.80 a share, about US$5.57, valuing it at roughly C$561m, according to Cannabis Equipment News, which also reported that Curaleaf has secured competition clearances in Germany and Canada for its rival US$5 offer, due to expire on 4 December. Organigram (OGI) trades at $0.8286, down 0.65%. Business of Cannabis covered the Organigram offer when it landed, and the contest is logged on our cannabis M&A tracker.

Curaleaf (CURLF) trades at $7.85, down 2.61%. On its third-quarter call, chief executive Boris Jordan said Curaleaf was prepared to raise its Aurora bid substantially, provided it gained access to due diligence, according to an earnings-call summary published by Yahoo Finance. The same summary records quarterly revenue of $353m, up 11%, and adjusted EBITDA of $78m, alongside sharp price compression in Germany. Curaleaf’s own share price matters to Aurora holders because its offer is part-paid in stock: Global News reported the October terms as 0.4013 Curaleaf shares plus US$1 in cash per Aurora share.

Village Farms (VFF) sits at $2.42, down 4.72%, the weakest of the Nasdaq-listed producers. Its third-quarter release on 9 November, filed with the SEC in an 8-K exhibit, reported consolidated net sales of $67m, record cannabis sales of $55m and international exports up 75% year on year to $20.8m. No fresh disclosure accounts for the current level.

Glass House’s OTC line (GLASF) trades at $2.26 after the steepest fall in the group. The company’s preliminary third-quarter release, filed with the SEC as a 6-K exhibit on 19 October, guided to revenue of $56.8m and identifies its primary US listing as NYSE: GLAS. The OTC quote may therefore be thin or stale, and no sourced announcement explains the move. Vext Science (VEXTF) sits at $0.13; its third-quarter revenue reached $14.9m, while adjusted EBITDA fell to $0.2m, according to GuruFocus.

Among the larger US multi-state operators, Green Thumb (GTBIF) holds above $6 at $6.12, down 1.61%, while Trulieve (CBWTF) sits at $2.49, down 2.35%, and Jushi (JUSHF) trades at $0.39. Cresco’s gain lifts it from a previous close of $0.477 to the $0.50 mark. None of the three larger operators has a sourced announcement that accounts for its current level, and each move is smaller than the 3.63% decline in MSOS.

Policy remains the sector’s slower-moving backdrop. Marijuana Moment reported on 13 November that the Senate Appropriations Committee proposes to extend the rider protecting state medical cannabis programmes without adopting the House’s anti-rescheduling provision; our rescheduling hub tracks the process. Tilray (TLRY) trades at $2.43, down 2.41%, ahead of its annual meeting on Wednesday 18 November, according to its investor relations page. Canopy Growth sits at $0.5612 and SNDL at $1.37. For earlier sessions, see our daily stocks coverage. Track all cannabis stocks live on the Business of Cannabis Stocks Tracker.

TopicsACBCBWTFCNBSCRLBFCURLFGLASFGTBIFIPW

Rob Dale

Rob runs technical and SEO strategy at Business of Cannabis and has a Master’s in Clinical Exercise Physiology. He blends search know-how with a solid grasp of clinical methods to spot what actually matters in new studies and regulations. Day to day, he helps shape evidence-based explainers and features, translating data into clear, useful insights for industry pros.

More from Rob

Spotted an error, or have a tip? Contact the newsroom.

Up next · Markets & Stocks

Cannabis Stocks Today — Friday 13 November 2026: Curaleaf trades at $8.06

Rob Dale · 13 November 2026

More